Market Place
Sourcing Support
All News #Library
Others
Vascarta Reports Positive Trial for Curcumin Gel VAS-101 in OA
01 Apr 2026 //
PR NEWSWIRE
Vascarta Interrupts Neuroinflammatory Cascade In Acute Sickle
04 Nov 2025 //
PR NEWSWIRE
Vascarta Adds Dr. Janet Loesberg to Leadership Team
28 Jul 2025 //
PR NEWSWIRE
Vascarta Partners with NIH for Phase 1 study of VAS-101
07 Jul 2025 //
PR NEWSWIRE
Vascarta starts Phase 1 Study of VAS-101 in sickle cell disease
15 Apr 2025 //
PR NEWSWIRE
Vascarta starts Phase I study of VAS101 in osteoarthritis
18 Mar 2025 //
PR NEWSWIRE
VAS101, Novel Curcumin Formulation Reverses Aging Hallmarks
17 Mar 2025 //
PR NEWSWIRE
Vascarta`s patented drug candidate for sickle cell disease
18 Feb 2025 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.